Behavioral, pharmacological, and molecular characterization of an amphibian cannabinoid receptor

Journal of Neurochemistry

Volumn 75, Issue 1, 2000, Pages 413-423

  Soderstrom, Ken ^a,c   Leid, Mark ^a   Moore, Frank L ^a   Murray, Thomas F ^b  

^a OREGON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c FLORIDA STATE UNIVERSITY   (United States)

Author keywords

Adenylate cyclase; Amphibian; Cannabinoid; G protein coupled receptor; Locomotor behavior; Sex behavior

Indexed keywords

CANNABINOID RECEPTOR; ADENYLATE CYCLASE; CANNABINOID; DRUG RECEPTOR; MESSENGER RNA; NANTRADOL; PHENANTHRIDINE DERIVATIVE;

AMPHIBIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; LIGAND BINDING; LOCOMOTION; MOLECULAR CLONING; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; AMINO ACID SEQUENCE; ANIMAL; BRAIN LEVEL; CHEMISTRY; CHO CELL; DRUG POTENTIATION; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HAMSTER; MALE; METABOLISM; MOLECULAR GENETICS; MOTOR ACTIVITY; PHYSIOLOGY; RADIOASSAY; SALAMANDER; SEQUENCE ALIGNMENT;

ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ANIMALS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; CANNABINOIDS; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; GENE EXPRESSION; MALE; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; PHENANTHRIDINES; RADIOLIGAND ASSAY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SALAMANDRIDAE; SEQUENCE ALIGNMENT; SEXUAL BEHAVIOR, ANIMAL; TRANSFECTION;

EID: 0033625543     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0750413.x     Document Type: Article

References (47)

1. s. J. Neurochem. 72, 2032-2038.
2. Bayewitch M., Avidor-Reiss T., Levy R., Barg J., Mechoulam R., and Vogel Z. (1995) The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett. 375, 143-147.
3. Bouaboula M., Bourrie B., Rinaldi-Carmona M., Shire D., Le Fur G., and Casellas P. (1995) Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J. Biol. Chem. 270, 13973-13980.
4. Bouaboula M., Poinot-Chazel C., Marchand J., Canat X., Bourrie B., Rinaldi-Carmona M., Calandra B., Le Fur G., and Casellas P. (1996) Signaling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur. J. Biochem. 237, 704-711.
5. Cheng Y. and Prusoff W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
6. Chin C. N., Lucas-Lenard J., Abadji V., and Kendall D. A. (1998) Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1. J. Neurochem. 70, 366-373.
7. Das S. K., Paria B. C., Chakraborty I., and Dey S. K. (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc. Natl. Acad. Sci. USA 92, 4332-4336.
8. De Petrocellis L., Melck D., Bisogno T., Milone A., and Di Marzo V. (1999) Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92, 377-387.
9. Devane W. A., Dysarz F. A. 3d, Johnson M. R., Melvin L. S., and Hewlett A. C. (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 34, 605-613.
10. Devane W. A., Breuer A., Sheskin T., Jarbe T. U., Eisen M. S., and Mechoulam R. (1992a) A novel probe for the cannabinoid receptor. J. Med. Chem. 35, 2065-2069.
11. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. (1992b) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
12. Elphick M. R. (1998) An invertebrate G-protein coupled receptor is a chimeric cannabinoid/melanocortin receptor. Brain Res. 780, 170-173.
13. Felsenstein J. (1988) Phylogenetics from molecular sequences: inference and reliability. Annu. Rev. Genet. 22, 521-565.
14. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., and Casellas P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61.
15. Garcia D. E., Brown S., Hille B., and Mackie K. (1998) Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J. Neurosci. 18, 2834-2841.
16. Gerard C. M., Mollereau C., Vassart G., and Parmentier M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
17. Glass M. and Felder C. C. (1997) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. J. Neurosci. 17, 5327-5333.
18. Howlett A. C. (1985) Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Mol. Pharmacol. 27, 429-436.
19. Howlett A. C. and Fleming R. M. (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26, 532-538.
20. Howlett A. C., Qualy J. M., and Khachatrian L. L. (1986) Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
21. Hsieh C., Brown S., Derleth C., and Mackie K. (1999) Internalization and recycling of the CB1 cannabinoid receptor. J. Neurochem. 73, 493-501.
22. Jin W., Brown S., Roche J. P., Hsieh C., Celver J. P., Kovoor A., Chavkin C., and Mackie K. (1999) Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J. Neurosci. 19, 3773-3780.
23. Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J. Y., Staub A., Garnier J. M., Mader S., et al. (1992) Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68, 377-395.
24. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
25. Mackie K., Lai Y., Westenbroek R., and Mitchell R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15, 6552-6561.
26. Martin B. R., Compton D. R., Thomas B. F., Prescott W. R., Little P. J., Razdan R. K., Johnson M. R., Melvin L. S., Mechoulam R., and Ward S. J. (1991) Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40, 471-478.
27. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
28. Mechoulam R., Ben-Shabat S., Hanus L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol 50, 83-90.
29. Merari A., Barak A., and Plaves M. (1973) Effects of 1(2)-tetrahydrocannabinol on copulation in the male rat. Psychopharmacologia (Berl.) 28, 243-246.
30. Moore F. L. and Miller L. J. (1984) Stress-induced inhibition of sexual behavior: corticosterone inhibits courtship behaviors of a male amphibian (Taricha granalosa). Horm. Behav. 18, 400-410.
31. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
32. Orchinik M., Murray T. F., and Moore F. L. (1991) A corticosteroid receptor in neuronal membranes. Science 252, 1848-1851.
33. Pertwee R. G. (1997) Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129-180.
34. Pertwee R. G. and Fernando S. R. (1996) Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder. Br. J. Pharmacol. 118, 2053-2058.
35. Pertwee R. G., Fernando S. R., Nash J. E., and Coutts A. A. (1996) Further evidence for the presence of cannabinoid CB1 receptors in guinea-pig small intestine. Br. J. Pharmacol. 118, 2199-2205.
36. Priller J., Briley E. M., Mansouri J., Devane W. A., Mackie K., and Felder C. C. (1995) Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. Mol. Pharmacol. 48, 288-292.
37. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., et al. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
38. Rinaldi-Carmona M., Barth F., Millan J., Derocq J. M., Casellas P., Congy C., Oustric D., Sarran M., Bouaboula M., Calandra B., Portier M., Shire D., Breliere J. C., and Le Fur G. L. (1998) SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284, 644-650.
39. Salomon Y. (1979) Adenylate cyclase assay. Adv. Cyclic Nucleotide Res. 10, 35-55.
40. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., Le Fur G., Caput D., and Ferrara P. (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270, 3726-3731.
41. Soderstrom K. and Johnson F. (2000) CB1 cannabinoid receptor expression in brain regions associated with zebra finch song control. Brain Res. 857, 151-157.
42. Song Z. H. and Bonner T. I. (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol. Pharmacol. 49, 891-896.
43. Stefano G. B., Salzet B., and Salzet M. (1997) Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. Brain Res. 753, 219-224.
44. Stefano G. B., Rialas C. M., Deutsch D. G., and Salzet M. (1998) Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. Brain Res. 793, 341-345.
45. Wiley J. L., Barrett R. L., Lowe J., Balster R. L., and Martin B. R. (1995) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34, 669-676.
46. Wise M. L., Soderstrom K., Murray T. F., and Gerwick W. H. (1996) Synthesis and cannabinoid receptor binding activity of conjugated triene anandamide, a novel eicosanoid. Experientia 52, 88-92.
47. Yamaguchi F., Macrae A. D., and Brenner S. (1996) Molecular cloning of two cannabinoid type 1-like receptor genes from the puffer fish Fugu rubripes. Genomics 35, 603-605.